Single-Use Roundtable Discussion is Featured in American Pharmaceutical Review Magazine

American Pharma Review 2019

A Roundtable panel fielded a series of questions centering on whether single-use technologies had finally become “standard” for biopharmaceutical manufacturing, and if there were unforeseen benefits/disadvantages to the adoption of this technology. Max Blomberg, Executive Director of Operations, participated on behalf of Meissner, along with representatives from companies like Catalent, Advantapure, BioPlan Associates, Pharmatech Associates, and Sartorius.

I would like to receive email notifications regarding new product announcements and industry events.
This field is for validation purposes and should be left unchanged.